Last reviewed · How we verify

NCT03464877

Prognostic Factors of a Favorable Outcome Following an Exercise Program for Soldiers With Low Back Pain

Completed NA Last updated 15 March 2018
What this trial tests

NA trial testing Multi-station full-body supervised exercise program in Low Back Pain in 104 participants. Completed in 27 April 2015.

Timeline
19 March 2013
Primary endpoint
14 March 2015
27 April 2015

Quick facts

Lead sponsorMarc Perron
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment104
Start date19 March 2013
Primary completion14 March 2015
Estimated completion27 April 2015
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Marc Perron

Who can join

18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low back pain (LBP) encompasses heterogeneous patients unlikely to respond to a unique treatment. Identifying sub-groups of low back pain may help to improve treatment outcomes. Our objective was to identify variables associated with a favorable outcome in soldiers with sub-acute and chronic LBP participating in a multi-station full-body supervised exercise program. The results obtained may permit generation of potential treatment effect modifiers that will eventually have to be validated before being recommended for clinical practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prognostic factors of a favorable outcome following a supervised exercise program for soldiers with sub-acute and chronic low back pain.
    Perron M, Gendron C, Langevin P, Leblond J, et al · · 2018 · cited 7× · PMID 29606114 · DOI 10.1186/s12891-018-2022-x

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03464877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing